Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in BIAF — bioAffinity Technologies, Inc.

CIK 1214717 BOSTON, MA
Back to BIAF Full portfolio

Position in BIAF

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$41,384
-$143,577 QoQ
Shares Held
3,398
+5.5% QoQ
Ownership
0.629%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 20 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BIAF Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $16,518,034,912 across 38 Diagnostics & Research names. BIAF ranks #37 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 8,382,401 $4,202,600,564
2 DHR
Danaher Corp /De/
 14,280,335 $2,720,118,210
3 IDXX
Idexx Laboratories Inc /De
 2,562,886 $1,349,205,704
4 A
Agilent Technologies, Inc.
 7,595,644 $1,008,929,392
5 WAT
Waters Corp /De/
 2,636,146 $988,660,195
6 IQV
Iqvia Holdings Inc.
 4,454,134 $860,627,771
7 MTD
Mettler Toledo International Inc/
 612,153 $782,031,578
8 NTRA
Natera, Inc.
 2,750,013 $746,491,028

All Filings in BIAF

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41,384 50,967
2026-03-31 $184,961 48,293
2025-12-31 $35,897 30,422
2025-06-30 $36,006 125,459
2025-03-31 $30,858 118,689
2024-12-31 $90,591 99,551
2024-09-30 $181,336 87,181
2024-06-30 $150,335 69,600
2024-03-31 $84,997 42,078
2023-12-31 $54,087 36,769